Oxaliprol (Oxaliplatin)

Oxaliplatin, the active ingredient in Oxaliprol, is a platinum compound presented as a intravenous solution for intraneous use. It treats colorectal cancer and is used in adult oncology patients. GNH USA supplies Oxaliprol as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliprol as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Oxaliplatin is employed in chemotherapy regimens targeting gastrointestinal malignancies.

- Colorectal cancer: enhances the efficacy of combination chemotherapy, aiming to shrink tumours and prolong survival. - Gastric cancer: used in combination with other agents to improve response rates and disease control. - Pancreatic cancer: incorporated in multi‑drug protocol to increase tumour shrinkage and potentially extend patient outcomes. - Advanced metastatic disease of the colon and rectum : provides palliative benefits by reducing tum ​ ​ ​ ​ ​ ​

The          ... ... ...